Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04300751 · ClinicalTrials.gov registry record · Phase 1

The Behavioral Effects of Opioids and Alcohol

A Phase 1 study of Opioid Use and Alcohol Drinking, sponsored by Sharon Walsh.

Completed
Registry status
Phase 1
Development phase
11
Enrollment target
1
Study location

NCT04300751 is a Phase 1 study of Opioid Use and Alcohol Drinking that has completed, run by Sharon Walsh. The registered enrollment target is 11 participants, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04300751, a Phase 1 study of Opioid Use and Alcohol Drinking, has completed, sponsored by Sharon Walsh.

COMPLETED
Registry status
Phase 1
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This study will examine the effects of doses of alcohol/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings of drug liking and other abuse-related effects; physiological outcomes) to determine the interaction effects of these compounds.

Interventions

  • DRUG Alcohol
  • DRUG Opioid Agonist

Study Locations (1)

Kentucky

  • University of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2021-03-24
Est. Completion 2024-11-09
Phase Phase 1

Sponsor

Sharon Walsh

4 total trials

What the Registry Record Tells You About NCT04300751

The ClinicalTrials.gov registry entry for NCT04300751 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,260-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Sharon Walsh, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Alcohol is the first listed.

NCT04300751 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT04300751 about?

NCT04300751 is a clinical study titled "The Behavioral Effects of Opioids and Alcohol". This study will examine the effects of doses of alcohol/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings of drug liking and other abuse-related effects; physiological outcomes) to determine the interaction...

What is the current status of trial NCT04300751?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2021-03-24. Estimated completion is 2024-11-09.

What conditions does trial NCT04300751 study?

This clinical trial studies the following conditions: Opioid Use, Alcohol Drinking.

What interventions are being tested in trial NCT04300751?

The interventions under investigation include: Alcohol (DRUG), Opioid Agonist (DRUG).

Who is sponsoring clinical trial NCT04300751?

This trial is sponsored by Sharon Walsh, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04300751 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.